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Hiroyuki Ogusu4, Shintaro Yoshida4, Kiyoyasu Fukushima4 and Michiaki Kai5Abstract
Objectives: This study aim to compare image quality and radiation doses between low-dose CT and follow-up
standard diagnostic CT for lung cancer screening.
Methods: In a single medical institution, 19 subjects who had been screened for lung cancer by low-dose CT
before going through follow-up standard diagnostic CT were randomly selected. Both CT image sets for all subjects
were independently evaluated by five specialized physicians.
Results: There were no significant differences between low-dose CT screening and follow-up standard diagnostic CT
for lung cancer screening in all 11 criteria. The concordance rate for the diagnoses was approximately 80% (p < 0.001)
for all categories. Agreement of the evaluation of all categories in the final diagnosis exceeded 94% (p < 0.001). Five
physicians detecting and characterizing the pulmonary nodules did not recognized the difference between low-dose
CT screening and follow-up standard diagnostic CT. With low-dose CT, the effective dose ranged between 1.3 and
3.4 mSv, whereas in the follow-up diagnostic CT, the effective dose ranged between 8.5 and 14.0 mSv.
Conclusion: This study suggests that low-dose CT can be effectively used as a follow-up standard diagnostic CT in
place of standard-dose CT in order to reduce the radiation dose.
Keywords: Lung cancer; Screening CT; Llow-dose; WAZA-ARI; ImPACTIntroduction
Lung cancer is the most common cause of death due to
cancer in Japan. In 2010, the lung cancer screening rate
was 23%, and 50,395 males and 19,418 females died
from lung cancer, which accounts for more than 1 in 17
deaths (Statistics and Information Department, Minister’s
Secretariat, Ministry of Health, Labour and Welfare 2011).
Lung cancer screening using computed tomography (CT)
has been carried out in Japan and the U.S. since 1993
(Kaneko et al. 1996), (Henschke et al. 1999). Many previous
reports have indicated that CT is a good screening tool for
the detection of small lung carcinomas. A high survival rate* Correspondence: k-ono@thcu.ac.jp
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in any medium, provided the original work is phas been reported for cases of lung cancer detected with
CT compared to chest radiography (Diederich et al. 2004),
(Jett 2005), (Libby et al. 2006), (Henschke et al. 2006)-
(Toyoda et al. 2008), (Fujikawa et al. 2008). However, it has
been reported that low-dose CT screening for lung cancer
may not significantly reduce the risk of advanced lung
cancer or death from lung cancer (Bach et al. 2007). In
November 2010, the National Lung Screening Trial
(NLST) reported from initial trial results in the U.S. that
20% fewer lung cancer deaths were seen in trial participants
that were screened with low-dose helical CT compared to
those who were screened with chest X-rays (National Lung
Screening Research Team 2011). The results of this trial
provided direct evidence of the benefits of low-dose helical
CT screening in an older, high-risk population with the
habit of cigarette smoking. Issues discussed concerningOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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ation, cost, radiation exposure and image quality. However,
low-dose CT screening may benefit individual at an
increased risk for lung cancer, but uncertainly exists about
the potential of screening and the generalizability of
results (Bach et al. 2012).
Current studies have shown that not all pulmonary
nodules detected by low-dose CT for lung cancer screening
are malignant, and low-dose CT results in over-diagnosis
caused by false-positive detection (Swensen et al. 2002),
(Croswell et al. 2010). A previous report proposed that
CT screening for lung cancer should be performed as a
baseline. If detection of non-calcified nodules smaller than
5.0 mm in diameter is possible, a repeated annual screen-
ing, and not immediate work-up, would be justified in
order to determine whether interim growth has occurred
(Hensckle et al. 2004). On the other hand, previous reports
have indicated that thin-section CT (TSCT) and high-
resolution diagnostic CT may be helpful in differentiating
small malignant nodules from benign nodules (Li et al.
2004), (Nakashima et al. 2006). Since small nodules are
very difficult to identify, periodic follow-up examinations
are required for diagnosis that take into account tumor
doubling time (Aoki et al. 2000). Over 70% of participants
had at least one follow-up CT. Non-calcified nodules are
common among CT-screened high-risk subjects and can
often be managed conservatively (Greenberg et al. 2012).
According to a questionnaire conducted by the Japanese
Society of Medical Checkups, low-dose CT screening was
conducted in only 30% institute in 2008 (Takizawa 2009).
This may be because low-dose CT is generally recognized
to create low quality images. The aim of this study was to
compare images and radiation doses between low-dose for
lung cancer screening and follow-up standard diagnostic
CT in order to evaluate the efficacy of low-dose CT for




In the present study, a database of low-dose CT images
acquired for lung cancer screening and follow-up standard
diagnostic CT images in the same patients were obtained
from a single hospital. Diagnoses of lung cancer resulting
from baseline low-dose CT screening and follow-up stand-
ard diagnostic CT are shown in Table 1. Results from the
present study including two-year follow-up data are shown.
The first nodule included was from May 2008 and the last
was from August 2010. A total of 19 subjects who were
examined with low-dose CT for lung cancer screening
before going through follow-up standard diagnostic CT
were randomly selected within 4 months of baseline
screening. The 19 subjects (mean age, 60.6 years; age range
45–82 years) included a total of 9 men (mean age,61.9 years; age range, 45–82 years) and 10 women (mean
age, 58.8 years; age range, 49–66 years). Among the 19
subjects, 11 nodules were found in 1 subject, four nodules
were found in 2 subjects, three nodules were found in 1
subject, and seven nodules were found in 1 subject.
Image sets from the low-dose CT and follow-up CT of all
19 subjects were evaluated by five specialized physicians
using 11 criteria related to malignancy that were developed
for this study. All images were assessed independently by
four radiologists with 31, 27, 21, and 8 years of experience
in general radiology and a pulmonologist with 25 years of
experience. Each image was ranked according to four-point
confidence scales. Images were presented on a LSC 1 M
monitor (EIZO Co. Ltd., Ishikawa, Japan) at a width and
level of 1600 HU and −600 HU, respectively. The scales
consisted of four sizes used to classify the lesions (20 ≤ S,
10 ≤ S < 20, 5 ≤ S < 10, S < 5), and four patterns of typical
tumor appearance (solid nodule, mixed ground-glass
opacity (GGO) or solid nodule and GGO, pure GGO, or
cavitary). A total of four categories of calcifications were
used (present, probably present, probably absent, absent),
four categories of boundaries (irregular with spiculation,
slightly irregular with spiculation, somewhat smooth,
smooth), four categories of shapes (round, oval, polygonal,
complex), four categories of margins (irregular with spicula-
tion, somewhat irregular with slight spiculation, somewhat
smooth, smooth), four categories of spiculations (present,
probably present, probably absent, absent), four categories
of glomerulus, four indrawn pleura signs, and four cat-
egories of air bronchogram (present, probably present,
probably absent, absent). The combined diagnostic results
of low-dose screening CT or follow-up standard diagnos-
tic CT were then assigned a score as follows: 1, annual
low-dose screening with CT is recommended; 2, suspi-
cion of a noncancerous lesion and a follow-up CT in a
hospital is recommended; 3, cancer or a noncancerous
lesion is suspected; and 4, cancer is suspected.
Diagnosis concordance rates between low-dose CT and
follow-up standard diagnostic CT were analyzed for 37
nodules. Diagnostic low-dose CT screening and follow-up
standard diagnostic CT provided information concerning
only nodules position. Correlation between low-dose
CT for lung cancer screening and follow-up standard
diagnostic CT of the lung was obtained by means of the
chi-square test for independence.
CT Techniques and procedures
All CT was performed on a MDCT scanner (16-slice
Toshiba Medical Systems Activion) at a single institution.
Low-dose CT screening was obtained with the following
technical parameters: 120 kV peak, 30–50 mA, a detector
thickness of 1 mm, an X-ray tube rotation speed of 0.75 s,
1 mm collimation × 16 mm, and a pitch factor of 1.438 mm
within one breath-holding period. Reconstruction slice
Table 1 Lung cancer diagnoses from baseline low-dose CT screening and follow-up standard diagnostic CT












1 57 M 1 43 15 15
Malignant nodule (adenocarcinoma
as pure GGO with multiloculated
cystic lesions )
2 46 M 1 15 13 13
Malignant nodule (pleural dissemination
of adenocarcinoma as solid nodule with
spiculation)
3 60 F 2 48 15 – 16 15 – 16
Two malignant nodules
(bronchiolalveolar carcinomaı
4 66 F 7 3 4 – 7 4 – 7 All benign nodules
5 70 M 3 25 6 6 All benign nodules
6 60 M 4 38 3 – 8 3 – 8 Benign nodules
7 61 F 1 41 6 6 Benign nodule
8 59 F 4 27 4 – 7 4 – 8 All benign nodules
9 82 M 2 44 14 – 17 13 – 16
Possibly benign nodule, benign
nodules
10 53 F 1 40 12 10 Benign nodule
11 65 F 1 35 11 10 Possibly benign nodule
12 49 F 1 74 6 5 Benign nodule
13 77 M 1 120 9 8 Benign nodule
14 60 M 2 119 4 – 7 4 – 8 All benign nodules
15 59 F 2 120 4 – 7 4 – 6 All benign nodules
16 61 F 1 118 7 7 Benign nodule
17 45 M 1 117 6 8 Benign nodule
18 64 M 1 120 9 8 Benign nodule
19 57 F 1 59 9 9 Possibly benign nodule






Number of detectors 16 16
kVp 120 120
mA 30–50 CT-AEC (SD = 70)
Seconds/rotation 0.75 0.75
mAs 22.5–37.5 Max 150
Pitch factor 1.438 1.188
Collimation 1 mm× 16 1 mm× 16
Reconstruction
slice thickness (mm) 3 1
slice interval (mm) 3 1
Lung field 1600/-600 1600/-600
Mediastinal 400/35 400/35
Function FC52 FC53
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Follow-up standard diagnostic CT was obtained with the
following technical parameters: 120 kV peak, AEC (max,
150 mAs) and detector thickness 1 mm, an X-ray tube ro-
tation speed of 0.75 second, 1 mm collimation × 16 mm,
and a pitch factor of 1.188 mm within one breath-holding
period. Reconstruction slice thickness was 1 mm, and
the slice interval was 1 mm with a CT reconstruction
algorithm. Low-dose CT screening and follow-up standard
diagnostic CT was performed with only a front view
scanogram. The protocols used for scanning and recon-
struction for the low-dose screening CT and follow-up
standard diagnostic CT are shown in Table 2.
Dose estimates
Tissue doses and effective doses of low-dose CT screening
and follow-up standard diagnostic CT were estimated by
the dose computational calculators, WAZA-ARI (Takahashi
et al. 2011), (Ban et al. 2011a,b), ImPACT (Imaging Per-
formance Assessment of CT scanners) (ImPACT: ctdi ta-
bles) and CT-EXPO v1.7.1 (Stamm & Nagel 2002). Dose
calculation in WAZA-ARI utilizes the Japanese voxel
Table 3 Lesion concordance rates between low-dose CT screening versus a follow-up standard diagnostic CT
Observers
Category A B C D E Average with lesion Statistically significant difference
Size of nodule (mm) 100% 100% 100% 100% 100% 100% p < 0.001
Pattern 92% 84% 78% 73% 84% 82% p < 0.001
Calcification 100% 100% 100% 100% 95% 99% p < 0.001
Boundary 95% 95% 76% 95% 84% 89% p < 0.001
Shape 81% 97% 95% 95% 86% 91% p < 0.001
Margin 89% 89% 92% 89% 95% 91% p < 0.001
Spiculation 84% 95% 97% 76% 97% 90% p < 0.001
Glomerulus 97% 95% 100% 92% 84% 94% p < 0.001
Indrawn pleura sign 92% 84% 95% 73% 89% 87% p < 0.001
Air bronchogram 86% 73% 84% 100% 70% 83% p < 0.001
Final diagnosis 97% 97% 95% 84% 95% 94% p < 0.001
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performed using the Particle and Heavy Ion Transport
code System (PHITS).
Results
Each of the five physicians analyzed 37 nodules in 19
subjects obtained by low-dose CT screening and follow-up
standard diagnostic CT. Diagnosis of lung cancer resulting
from baseline low-dose CT screening and follow-up
standard diagnostic CT is shown in Table 3. There were
no significant differences between low-dose CT and
follow-upstandard diagnostic CT for lung cancer screening
in all 11 criteria. The concordance rate for the diagnoses
was approximately 80% (p < 0.001) for all categories.
Agreement of the evaluation of all categories in the final
diagnosis exceeded 94% (p < 0.001). Of the 19 subjects
evaluated (9 men and 10 women; mean age, 60.6 years)
there were 3 (2 men and 1 women; mean age, 54.3 years)
malignant nodules and 16 (7 men and 9 women; meanLow-dose CT screening image
Figure 1 Low-dose CT screening image and follow-up diagnostic CT i
and interval of 3 mm. Follow-up diagnostic CT image with an image slice t
presenting as pure GGO with multiloculated cystic lesions in the right uppage, 61.8 years) possibly benign nodules. The size of
possibly benign nodules was 3 to 16 mm, and that of
malignant nodules was 13 to 16 mm. The mean size of
the four malignant nodules (14.6 mm) was larger than
that of the 33 possibly benign nodules (6.8 mm).
Evaluation concerning the nodules diagnosed as malig-
nant accorded with the final diagnosis in the subjects. All
physicians diagnosed 4 nodules in 3 subjects as malignant
or suspected malignancy during follow-up examination.
The four malignant nodules included an adenocarcinoma
with cavitary lung lesion, pleural dissemination of an
adenocarcinoma, and two bronchioloalveolar carcinomas,
as shown in Figures 1, 2, 3 and 4. Two patient (3 nodules)
diagnoses were confirmed at surgery, and 1 patient was
diagnosed with inoperable lung cancer.
Dose to the internal organs under auto exposure control
(AEC) was calculated by WAZA-ARI using the tube
current obtained by follow-up standard diagnostic CT
clinical data using the Toshiba Aquilion 16-MDCTFollow-up diagnostic CT image
mage. Low-dose CT screening image with an image slice thickness
hickness and interval of 1 mm. 57-year-old man with adenocarcinoma
er lobe. Result of pathological staging operable patient (T1N0M0).
Low-dose CT screening image Follow-up diagnostic CT image
Figure 2 Low-dose CT screening image and follow-up diagnostic CT image. Low-dose CT screening image with an image slice thickness
and interval of 3 mm. Follow-up diagnostic CT image with an image slice thickness and interval of 1 mm. A 46-year-old man with pleural
dissemination and adenocarcinoma presenting as a solid nodule with spiculation in the right upper lobe. Results of pathological staging in an
operable patient (T4N2M1).
Ono et al. SpringerPlus 2013, 2:393 Page 5 of 8
http://www.springerplus.com/content/2/1/393(instead of the Toshiba Activity 16-MDCT). Radiation
doses produced by lung CT with WAZA-ARI, ImPACT
and CT-Expo indicated CTDIvol from the 16-slice Toshiba
Medical System Activion are shown in Table 4. The average
dose-length product (DLP) was 59.8 mGy × cm for
low-dose TSCT using 30 mA for clinical data in 2 men
and 2 women. The average DLP was 99.7 mGy × cm
for low-dose CT using 50 mA in 7 men and 8 women.
With low-dose TSCT, the doses calculated by WAZA-ARI
ranged between 2.7 to 5.2 mGy in the lung with an 1.5 to
2.8 mSv effective dose, and with a follow-up standard
diagnostic CT calculated dose of 15.1 to 25.2 mGy in lung
with an 9.4. to 13.8 mSv effective dose (ICRP 103). With
the low-dose CT using ImPACT, the dose was 5.8 mGy in
the lung with a 3.4 mSv effective dose (ICRP 130), but
with the follow-up standard diagnostic CT, it was 23 mGy
in lung with a 14.0 mSv effective dose (ICRP 103). Using
CT-EXPO, the dose was 5.3 mGy with a 2.8 to 3.3-mSvLow-dose CT screening image
Figure 3 Low-dose CT screening image and follow-up diagnostic CT i
interval of 3 mm. Follow-up diagnostic CT image with an image slice thick
carcinoma (adenocarcinoma in situ) with mixed ground-glass opacity or pueffective dose (ICRP 60) with the low-dose CT, while the
lung dose ranged between 21 and 21.2 mGy and the
effective dose between 11 and 13 mSv (ICRP 60) with a
follow-up standard diagnostic CT.
Discussion
This is the most important finding in smaller nodules
concerning improvement of survival. Many previous re-
ports suggest the merit of early detection (Suzuki et al.
2009), (National Cancer Institute 2011). The problem is
that low-dose CT for lung cancer screening creates an
endemic of over-diagnosis through false-positives because
of the high sensitivity and capacity for detection. The
present study revealed that only a small number of
low-dose CT scans used for lung cancer screening result in
over-diagnosis compared to follow-up standard diagnostic
CT. These features appear to be a specific characteristic of
high-resolution CT.Follow-up diagnostic CT image
mage. Low-dose CT screening image with a slice thickness and
ness and interval of 1 mm. A 60-year-old woman with bronchioalveolar
re ground-glass opacity in the right middle lobe (T1N0M0).
Low-dose CT screening image Follow-up diagnostic CT image
Figure 4 Low-dose CT screening image and follow-up diagnostic CT image. Low-dose CT screening image with a slice thickness and
interval of 3 mm. Follow-up diagnostic CT image with an image slice thickness and interval of 1 mm. A 60-year-old woman with bronchioalveolar
carcinoma (adenocarcinoma in situ) as mixed ground-glass opacity or pure ground-glass opacity in the right lower lobe (T1N0M0).
Table 4 Estimated radiation dose of lung CT and CTDIvol with the 16-slice Toshiba medical systems aquilion
CT Scans Low-dose CT scan
CT dose soft WAZA-ARI ImPACT CT-EXPO
Auto exposure control Without AEC Without AEC Without AEC
Sex Male Female Average adult Male Female
mAs 22.5 – 37.5 22.5 - 37.5 37.5 37.5 37.5
Lung (mGy) 2.7 – 4.6 3.1 – 5.2 5.8 5.3 5.3
Liver (mGy) 2.7 – 4.5 2.8 – 4.7 4.8 4.7 4.8
Breast (mGy) 2.1 – 3.5 2.2 – 3.6 4.3 5.4 5.4
ICRP103 (mSv) 1.7 – 2.8 1.5 – 2.5 3.4 - -
ICRP60 (mSv) 1.5 – 2.5 1.3 – 2.2 2.9 2.8 3.3
DLP (mGy cm) 84 – 140 71 – 119 168 203 203
CTDIvol (mGy) 2.1 – 3.5 2.1 – 3.5 3.5 3.3 3.3
Average of DLP indicated value of 16 Toshiba rows CT (mGy x cm) 59.8 (n = 4) – 99.7(n = 15)
CT Scans Follow–up standard diagnostic CT scan
CT dose soft WAZA–ARI ImPACT CT–EXPO
Auto exposure control With AEC Without AEC Without AEC
Sex Male Female Average adult Male Female
mAs 150 (Max) 150 (Max) 150 150 150
Lung (mGy) 15.1 – 22.1 17.9 – 25.2 23.0 21.0 21.2
Liver (mGy) 18.6 – 21.5 19.0 – 22.5 19.0 18.7 19.3
Breast (mGy) 10.4 – 17.0 11.6 – 17.5 17.0 21.4 21.4
ICRP103 (mSv) 11.1 – 13.8 9.4 – 12.1 14.0 - -
ICRP60 (mSv) 10.3 – 12.5 8.5 – 10.6 12.0 11 13
DLP (mGy cm) 545 – 679 455 – 574 673 810 810
CTDIvol (mGy) 13.5 – 16.8 13.3 – 16.8 13.9 13.3 13.3
Average of DLP indicated value of 16 Toshiba rows CT (mGy x cm) 474.7 (n = 19)
*These radiation transport calculations were performed using the JM phantom with WAZA-ARI, and the MIRD-5 type phantom with ImPACT and the GSF phantom
with CT-Expo. The JM phantom was constructed from CT images of a healthy Japanese male adult. The height and the weight were 171 cm and 65 kg,
respectively. The MIRD-5 type phantom was a hermaphroditic adult. For the MIRD–5 type phantom, the height and the weight were 174 cm and 70 kg,
respectively. For the GSF-ADAM phantom, the height and the weight were 170 cm and 70 kg, respectively. For the GSF-EVA phantom, the height and the weight
were 160 cm and 60 kg, respectively.
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Committee on the Effects of Atomic Radiation) 2008
report, the effective dose of natural background radiation
is 2.4 mSv (2010). A previous study reported that the
background dose was 8.71 mGy in the lung, with an
effective dose that ranged between 3.61 and 3.64 mSv
(ICRP 60) using an anthropomorphic phantom, which is a
model of a Japanese adult (RANDO; Alderson Research
Laboratory, Salem, NY, USA, 163 cm height, 53 kg weight,
without legs or arms) (Nishizawa et al. 1996). The scan-
ning parameters for lung cancer used for a single spiral
CT were 120 kVp and 50 mA, a slice thickness of 10 mm,
tube rotation speed of 2 s, a reconstructed image pitch of
10 mm, and a table speed of 10 mm/s. The effective dose
of the low-dose CT ranged between 1.6 and 3.4 mSv.
Comparison of effective doses between 10-mm slice
thickness and 1-mm slice thickness was the same using
modern CT units. In digital and analog chest X-ray sys-
tems, the radiation dose was extremely low, with averages
ranging between 73 and 198 μGy. However, a phantom
study that simulated Noguchi’s Type A small adenocarcin-
oma revealed that the detection rate was very low by
digital and analog chest X-ray systems (Ono et al. 2005).
The present study indicated that low-dose CT screening
provided diagnoses similar to standard diagnostic CT. The
image quality of low-dose CT may be high enough for it
to be used for the diagnosis of lung cancer as a method of
repeated follow up. We suggest that low-dose CT for lung
cancer screening should be used as a follow-up to standard
diagnostic CT in place of standard-dose CT. The dose to
the lung in low-dose CT is approximately one-sixth that
of standard CT. Furthermore, it is suggested that in a
high-risk population with the habit of cigarette smoking,
annual low-dose CT for lung cancer screening is modestly
recommended. It is important to create an effective low-
dose CT protocol for lung cancer screening that takes into
consideration both radiation dose and image quality.Conclusion
Since small nodules in the lungs are very difficult to
identify, periodic follow-up examinations are required
for diagnosis of lung cancer. This study suggests that
low-dose CT can be effectively used as a follow-up
standard diagnostic CT in place of standard-dose CT in
order to reduce the radiation dose.Competing interest
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